Docking and molecular dynamics studies of potential new leads against DBL3x derived from chondroitin sulfate A (CSA): a new approach for the treatment of malaria

Joao P. M. Spadetoa Federal Institute of Education Science and Technology of Espı́rito Santo, Vila Velha, Brazil

https://orcid.org/0000-0002-4193-8797

Rodrigo A. Cormanichb Institute of Chemistry, University of Campinas, Campinas, Brazil

https://orcid.org/0000-0001-7659-1749

Tanos C. C. Francac Laboratory of Molecular Modeling Applied to the Chemical and Biological Defense (LMCBD), Military Institute of Engineering, Rio de Janeiro, Brazil;d Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove, Czech Republic;e Université du Quebec, INRS-Centre Armand-Frapier Santé Biotechnologie, Laval, Canada

https://orcid.org/0000-0002-6048-8103

Steven R. LaPlantee Université du Quebec, INRS-Centre Armand-Frapier Santé Biotechnologie, Laval, Canada

https://orcid.org/0000-0003-2835-5789

Arlan S. Goncalvesa Federal Institute of Education Science and Technology of Espı́rito Santo, Vila Velha, Brazil;f Federal Institute of Education Science and Technology of Espírito Santo, Unit Vitória, Espírito Santo, Brazil;g Federal University of Espírito Santo – Unit Goiabeiras, Vitoria, BrazilCorrespondence[email protected]

https://orcid.org/0000-0002-5965-3191

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Arif Jamal Siddiqui, Sadaf Jahan, Mitesh Patel, Abdelmushin Abdelgadir, Wael Alturaiki, Fevzi Bardakci, Manojkumar Sachidanandan, Riadh Badraoui, Mejdi Snoussi & Mohd Adnan. (2023) Identifying novel and potent inhibitors of EGFR protein for the drug development against the breast cancer. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-13.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Docking and molecular dynamics studies of potential new leads against DBL3x derived from chondroitin sulfate A (CSA): a new approach for the treatment of malaria

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Docking and molecular dynamics studies of potential new leads against DBL3x derived from chondroitin sulfate A (CSA): a new approach for the treatment of malaria

Citations (1)

Read on this site (1)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date